Microtubule destabilizers have been shown to activate stimulator of interferon genes (STING)-interferon regulatory factor 3 (IRF3) dependent production of IFN-β and downstream interferon-stimulated genes (ISGs) in both immune and triple negative breast cancer cells (12). Here, IRF3 is linked to triple-negative breast carcinoma.